Innate allorecognition

Immunological Reviews

Volumn 258, Issue 1, 2014, Pages 145-149

  Oberbarnscheidt, Martin H ^a,b   Lakkis, Fadi G ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Allorecognition; Dendritic cells; Innate immune system; Monocytes; Transplantation

Indexed keywords

ALLOGRAFT; ALLOIMMUNITY; ALLOTRANSPLANTATION; ANTIGEN RECOGNITION; CELL MATURATION; DENDRITIC CELL; GRAFT REJECTION; HOST; HUMAN; HYPOTHESIS; INNATE IMMUNITY; MICROBIAL IMMUNITY; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW; XENOTRANSPLANTATION; ANIMAL; ANTIGEN PRESENTING CELL; GRAFT SURVIVAL; IMMUNOLOGY; MOLECULAR GENETICS; ORGAN TRANSPLANTATION; TRANSPLANTATION TOLERANCE; TREATMENT OUTCOME;

ALLOGRAFTS; ANIMALS; ANTIGEN-PRESENTING CELLS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNITY, INNATE; MOLECULAR SEQUENCE DATA; ORGAN TRANSPLANTATION; TRANSPLANTATION TOLERANCE; TREATMENT OUTCOME;

EID: 84893558109     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/imr.12153     Document Type: Review

References (50)

1. Iwasaki A, Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science 2010;327:291-295.
2. Palm NW, Medzhitov R. Pattern recognition receptors and control of adaptive immunity. Immunol Rev 2009;227:221-233.
3. Beutler BA. TLRs and innate immunity. Blood 2009;113:1399-1407.
4. Klein J. Biology of the Mouse Histocompatibility-2 Complex: Principles of Immunogenetics Applied to a Single System. Heidelberg, Berlin: Springer-Verlag, 1975.
5. Sykes M, Wood K, Sachs DH. Transplantation immunology. In: Paul WE ed. Fundamental Immunology. 6th edn. Philadelphia, PA: Woleters Kluwer/Lippincott Williams & Wilkins, 2008:1426-1488.
6. Bonney EA, Matzinger P. The maternal immune system's interaction with circulating fetal cells. J Immunol 1997;158:40-47.
7. Pearse AM, Swift K. Allograft theory: transmission of devil facial-tumour disease. Nature 2006;439:549.
8. Murgia C, Pritchard JK, Kim SY, Fassati A, Weiss RA. Clonal origin and evolution of a transmissible cancer. Cell 2006;126:477-487.
9. Felix NJ, et al. Alloreactive T cells respond specifically to multiple distinct peptide-MHC complexes. Nat Immunol 2007;8:388-397.
10. Janeway CA, Jr. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 1989;54(Pt 1):1-13.
11. Medzhitov R, PrestonHurlburt P, Janeway CA. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997;388:394-397.
12. Poltorak A, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998;282:2085-2088.
13. Broz P, Monack DM. Newly described pattern recognition receptors team up against intracellular pathogens. Nat Rev Immunol 2013;13:551-565.
14. Dierselhuis M, Goulmy E. The relevance of minor histocompatibility antigens in solid organ transplantation. Curr Opin Organ Transplant 2009;14:419-425.
15. Rao DA, Pober JS. Endothelial injury, alarmins, and allograft rejection. Crit Rev Immunol 2008;28:229-248.
16. Rock KL, Lai JJ, Kono H. Innate and adaptive immune responses to cell death. Immunol Rev 2011;243:191-205.
17. Zelenay S, Reis e Sousa C. Adaptive immunity after cell death. Trends Immunol 2013;34:329-335.
18. Tsung A, et al. HMGB1 release induced by liver ischemia involves toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J Exp Med 2007;204:2913-2923.
19. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006;440:237-241.
20. Chen CJ, Kono H, Golenbock D, Reed G, Akira S, Rock KL. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med 2007;13:851-856.
21. Iyer SS, et al. Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc Natl Acad Sci USA 2009;106:20388-20393.
22. Sims GP, Rowe DC, Rietdijk ST, Herbst R, Coyle AJ. HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 2010;28:367-388.
23. Huang Y, et al. Extracellular hmgb1 functions as an innate immune-mediator implicated in murine cardiac allograft acute rejection. Am J Transplant 2007;7:799-808.
24. Shi Y, Evans JE, Rock KL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 2003;425:516-521.
25. Shi Y, Galusha SA, Rock KL. Cutting edge: elimination of an endogenous adjuvant reduces the activation of CD8 T lymphocytes to transplanted cells and in an autoimmune diabetes model. J Immunol 2006;176:3905-3908.
26. Honda K, Littman DR. The microbiome in infectious disease and inflammation. Annu Rev Immunol 2012;30:759-795.
27. Goldstein DR, Tesar BM, Akira S, Lakkis FG. Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection. J Clin Invest 2003;111:1571-1578.
28. Thornley TB, et al. TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts. J Immunol 2006;176:1561-1570.
29. Walker WE, Nasr IW, Camirand G, Tesar BM, Booth CJ, Goldstein DR. Absence of innate MyD88 signaling promotes inducible allograft acceptance. J Immunol 2006;177:5307-5316.
30. Wang T, et al. Infection with the intracellular bacterium, Listeria monocytogenes, overrides established tolerance in a mouse cardiac allograft model. Am J Transplant 2010;10:1524-1533.
31. Chakraverty R, et al. An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissues. J Exp Med 2006;203:2021-2031.
32. Tesar BM, Zhang J, Li Q, Goldstein DR. TH1 immune responses to fully MHC mismatched allografts are diminished in the absence of MyD88, a toll-like receptor signal adaptor protein. Am J Transplant 2004;4:1429-1439.
33. McKay D, Shigeoka A, Rubinstein M, Surh C, Sprent J. Simultaneous deletion of MyD88 and Trif delays major histocompatibility and minor antigen mismatch allograft rejection. Eur J Immunol 2006;36:1994-2002.
34. Hutton MJ, Westwell-Roper C, Soukhatcheva G, Plesner A, Dutz JP, Verchere CB. Islet allograft rejection is independent of toll-like receptor signaling in mice. Transplantation 2009;88:1075-1080.
35. Oberbarnscheidt MH, et al. Type I interferons are not critical for skin allograft rejection or the generation of donor-specific CD8+ memory T cells. Am J Transplant 2010;10:162-167.
36. Li H, et al. Graft-versus-host disease is independent of innate signaling pathways triggered by pathogens in host hematopoietic cells. J Immunol 2011;186:230-241.
37. Bingaman AW, et al. Vigorous allograft rejection in the absence of danger. J Immunol 2000;164:3065-3071.
38. Anderson C, Carroll J, Gallucci S, Ridge J, Cheever A, Matzinger P. Testing time-, ignorance-, and danger-based models of tolerance. J Immunol 2001;166:3663-3671.
39. Anderson CC, Matzinger P. Immunity or tolerance: opposite outcomes of microchimerism from skin grafts. Nat Med 2001;7:80-87.
40. Chan WF, Perez-Diez A, Razavy H, Anderson CC. The ability of natural tolerance to be applied to allogeneic tissue: determinants and limits. Biol Direct 2007;2:10.
41. Zecher D, et al. NK cells delay allograft rejection in lymphopenic hosts by downregulating the homeostatic proliferation of CD8+ T cells. J Immunol 2010;184:6649-6657.
42. Li HW, Sachs J, Pichardo C, Bronson R, Zhao G, Sykes M. Nonalloreactive T cells prevent donor lymphocyte infusion- induced graft-versus-host disease by controlling microbial stimuli. J Immunol 2012;189:5572-5581.
43. Zecher D, van Rooijen N, Rothstein D, Shlomchik W, Lakkis F. An innate response to allogeneic nonself mediated by monocytes. J Immunol 2009;183:7810-7816.
44. Liu W, Xiao X, Demirci G, Madsen J, Li XC. Innate NK cells and macrophages recognize and reject allogeneic nonself in vivo via different mechanisms. J Immunol 2012;188:2703-2711.
45. Sporri R, Reis e Sousa C. Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function. Nat Immunol 2005;6:163-170.
46. Takenaka K, et al. Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nat Immunol 2007;8:1313-1323.
47. Barclay AN, van den Berg TK. The interaction between signal regulatory protein alpha (SIRPa) and CD47: structure, function, and therapeutic target. Annu Rev Immunol 2014;32:25-50.
48. Ide K, et al. Role for CD47-SIRPalpha signaling in xenograft rejection by macrophages. Proc Natl Acad Sci USA 2007;104:5062-5066.
49. Wang H, Wu X, Wang Y, Oldenborg PA, Yang YG. CD47 is required for suppression of allograft rejection by donor-specific transfusion. J Immunol 2010;184:3401-3407.
50. Burnet FM. "Self-recognition" in colonial marine forms and flowering plants in relation to the evolution of immunity. Nature 1971;232:230-235.